WRBY

WRBY

USD

Warby Parker Inc. Class A Common Stock

$15.520-0.210 (-1.335%)

Reaalajas hind

Healthcare
Medical Instruments & Supplies
Ameerika Ühendriigid

Hinnagraafik

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$15.730

Kõrge

$15.815

Madal

$15.300

Maht

0.43M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

1.9B

Tööstusharu

Medical Instruments & Supplies

Riik

United States

Kauplemisstatistika

Keskmine maht

2.30M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $11.66Praegune $15.520Kõrge $28.68

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 27. apr 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

WRBY: Warby Parker Inc. Class A Common Stock - What's Happening and What to Watch

Stock Symbol: WRBY Generate Date: 2025-04-27 15:38:53

Alright, let's break down what's been going on with Warby Parker stock lately and what the tea leaves seem to suggest. We'll look at the recent news buzz, check out the price chart, and see what the AI model is predicting.

Recent News Buzz: A Mixed Bag from the Pros

Looking at the headlines from the past few weeks, it's a bit of a mixed picture from the Wall Street analysts who cover Warby Parker.

On the positive side, Loop Capital actually upgraded the stock from a "Hold" to a "Buy" and slapped a $27 price target on it. That's a pretty strong vote of confidence. Plus, Goldman Sachs and JMP Securities are still saying "Buy" or "Market Outperform," which is analyst-speak for "we think it's going to do better than the average stock."

But here's the catch: several analysts, including Goldman Sachs, JMP Securities, Piper Sandler, and Stifel, have lowered their price targets. Goldman Sachs dropped theirs from $29 all the way down to $18. Piper Sandler went from $30 to $20, JMP from $30 to $22, and Stifel from $25 to $18. So, while some still like the stock, they seem to think its potential upside isn't as high as they previously did.

The other big piece of news is that Warby Parker is set to announce its first-quarter financial results on May 8th. This is a key date. Earnings reports can often cause big swings in the stock price, depending on whether the results beat or miss expectations.

So, the vibe from the news is a bit contradictory: analysts mostly still rate it positively, but they've become less optimistic about how high the price might go. And everyone's waiting for those Q1 numbers.

Price Check: A Recent Dip and Some Stability

Now, let's look at what the stock price itself has been doing. If you check the chart over the last few months, it's been a bit of a tough ride. The stock was trading in the mid-to-high $20s back in January and February. Then, starting in late February and continuing into March and early April, it took a significant tumble, dropping into the mid-teens.

More recently, in April, the price seems to have found a bit of a floor, trading mostly between $14 and $16. The last price point we have is around $15.52 (from April 25th).

What about the very near future? The AI prediction model suggests the price might stay flat today (0.00% change) but sees a potential slight bump over the next couple of days, predicting a rise of about 2.4% tomorrow and another 3.8% the day after. This hints that the AI sees some potential for a short-term upward move from the current level.

Putting It Together: What Might This Mean?

Okay, let's connect the dots. The stock has dropped significantly, likely reflecting some of the lowered expectations from analysts and perhaps broader market conditions. However, some analysts still maintain positive ratings, and one even upgraded it recently. The price has stabilized in the mid-$15 range, and the AI model is forecasting a small upward move in the immediate future.

Given this mix, the apparent near-term leaning seems cautious but with potential for a short-term bounce or consolidation ahead of earnings. It doesn't scream "strong buy" or "urgent sell" right now for everyone. For many, a "hold" or "watch" approach might make sense until the earnings report clarifies the company's performance.

However, for investors with a higher risk tolerance or those looking for short-term trading opportunities, the current price area might be interesting. The recommendation data points to potential entry points around $15.45 to $15.58, which is right where the stock has been trading. This level could be seen as a potential area to consider if you believe the recent price drop is overdone and the stock might bounce, especially with the AI predicting a slight rise.

If you were considering getting in around this level, where might you manage risk? The recommendation data suggests a potential stop-loss around $13.98. This level is below some recent lows and could be a point to consider exiting if the price continues to fall, helping to limit potential losses. On the flip side, a potential take-profit level is suggested around $16.83. This could be a target if the stock does bounce, perhaps hitting some minor resistance along the way. Remember, these are just potential levels based on the data provided, not guarantees.

Company Context

Just a quick reminder about Warby Parker: they're primarily an eyewear company selling glasses, contacts, and offering eye exams, operating both online and through physical stores. They're in the Healthcare sector, specifically Medical Instruments & Supplies. Their business model is direct-to-consumer. The upcoming earnings report will give us a clearer picture of how that model is performing financially right now. The company's P/E ratio is quite high (48.5x) relative to its reported revenue growth (17.8%) and negative Return on Equity (-6.4%), and they carry a notable amount of debt (Debt-to-Equity 66.27%), according to the recommendation data. These are fundamental factors that investors often consider alongside news and price trends.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Seotud uudised

Analyst Upgrades

Goldman Sachs Maintains Buy on Warby Parker, Lowers Price Target to $18

Goldman Sachs analyst Brooke Roach maintains Warby Parker with a Buy and lowers the price target from $29 to $18.

Vaata rohkem
Goldman Sachs Maintains Buy on Warby Parker, Lowers Price Target to $18
BusinessWire

Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025

Warby Parker Inc. (NYSE:WRBY) (the "Company"), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the first quarter ended March 31, 2025 will be released

Vaata rohkem
Warby Parker to Announce First Quarter 2025 Financial Results on May 8, 2025
Analyst Upgrades

Loop Capital Upgrades Warby Parker to Buy, Announces $27 Price Target

Loop Capital analyst Anthony Chukumba upgrades Warby Parker from Hold to Buy and announces $27 price target.

Vaata rohkem
Loop Capital Upgrades Warby Parker to Buy, Announces $27 Price Target
Analyst Upgrades

JMP Securities Maintains Market Outperform on Warby Parker, Lowers Price Target to $22

JMP Securities analyst Devin Ryan maintains Warby Parker with a Market Outperform and lowers the price target from $30 to $22.

Vaata rohkem
JMP Securities Maintains Market Outperform on Warby Parker, Lowers Price Target to $22
Analyst Upgrades

Piper Sandler Maintains Overweight on Warby Parker, Lowers Price Target to $20

Piper Sandler analyst Anna Andreeva maintains Warby Parker with a Overweight and lowers the price target from $30 to $20.

Vaata rohkem
Piper Sandler Maintains Overweight on Warby Parker, Lowers Price Target to $20
Analyst Upgrades

Stifel Maintains Hold on Warby Parker, Lowers Price Target to $18

Stifel analyst Jim Duffy maintains Warby Parker with a Hold and lowers the price target from $25 to $18.

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 27. apr 2025, 15:35

LangevNeutraalneTõusev

73.4% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Agressiivne
Kauplemisjuhend

Sisenemispunkt

$15.45

Võta kasum

$16.83

Peata kahjum

$13.98

Põhitegurid

PDI 8.9 on MDI 5.7 kohal ADX-iga 10.7, mis viitab tõusutrendile
Praegune hind on tugitasemele ($15.41) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 9.3x keskmisest (30,380), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0153 on signaalijoone 0.0050 kohal, mis viitab tõusvale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.